CAS Medical Systems, Inc. (Nasdaq:CASM) today announced the presentation of a comparative study showing the superior accuracy of its FORE-SIGHT® Absolute Tissue Oximeter against other available oximeters. Study has been presented on annual meeting of the American Society of Anesthesiologists (ASA) in Chicago, IL. Thomas M. Patton, President and CEO of CASMED, commented: “This comprehensive […]